New celiac drug trial aims to tame gluten reactions
Disease control
Recruiting now
This early-stage trial tests a new medicine called VTP-1000 in 45 adults with celiac disease. The goal is to see if it is safe and how the body handles it, especially when exposed to gluten. Participants will receive either the drug or a placebo, and some will take a controlled g…
Phase: EARLY_PHASE1 • Sponsor: Barinthus Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC